GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » ROA %

Invictus MD Strategies (Invictus MD Strategies) ROA %

: -20.55% (As of Oct. 2019)
View and export this data going back to 2015. Start your Free Trial

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Invictus MD Strategies's annualized Net Income for the quarter that ended in Oct. 2019 was $-19.99 Mil. Invictus MD Strategies's average Total Assets over the quarter that ended in Oct. 2019 was $97.31 Mil. Therefore, Invictus MD Strategies's annualized ROA % for the quarter that ended in Oct. 2019 was -20.55%.

The historical rank and industry rank for Invictus MD Strategies's ROA % or its related term are showing as below:

IVITF's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.72
* Ranked among companies with meaningful ROA % only.

Invictus MD Strategies ROA % Historical Data

The historical data trend for Invictus MD Strategies's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
ROA %
-178.59 -2.39 -40.89 -29.44 -25.74

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
ROA % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.13 -37.65 -12.15 -35.41 -20.55

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies ROA % Distribution

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's ROA % distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's ROA % falls into.



Invictus MD Strategies ROA % Calculation

Invictus MD Strategies's annualized ROA % for the fiscal year that ended in Jan. 2019 is calculated as:

ROA %=Net Income (A: Jan. 2019 )/( (Total Assets (A: Jan. 2018 )+Total Assets (A: Jan. 2019 ))/ count )
=-26.851/( (92.885+115.72)/ 2 )
=-26.851/104.3025
=-25.74 %

Invictus MD Strategies's annualized ROA % for the quarter that ended in Oct. 2019 is calculated as:

ROA %=Net Income (Q: Oct. 2019 )/( (Total Assets (Q: Jul. 2019 )+Total Assets (Q: Oct. 2019 ))/ count )
=-19.992/( (99.928+94.687)/ 2 )
=-19.992/97.3075
=-20.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Oct. 2019) net income data. ROA % is displayed in the 30-year financial page.


Invictus MD Strategies  (OTCPK:IVITF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Oct. 2019 )
=Net Income/Total Assets
=-19.992/97.3075
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-19.992 / 2.544)*(2.544 / 97.3075)
=Net Margin %*Asset Turnover
=-785.85 %*0.0261
=-20.55 %

Note: The Net Income data used here is four times the quarterly (Oct. 2019) net income data. The Revenue data used here is four times the quarterly (Oct. 2019) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Invictus MD Strategies ROA % Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

By Marketwired Marketwired 10-17-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By Marketwired Marketwired 12-14-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

By Marketwired Marketwired 09-11-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

By Marketwired Marketwired 06-26-2019

UPDATE ON ACREAGE PHARMS LTD.

By Marketwired Marketwired 06-12-2019